L
Lu-ming Yao
Researcher at Xiamen University
Publications - 5
Citations - 395
Lu-ming Yao is an academic researcher from Xiamen University. The author has contributed to research in topics: Apoptosis & Autophagy. The author has an hindex of 5, co-authored 5 publications receiving 285 citations.
Papers
More filters
Journal ArticleDOI
Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway
Wei-jia Wang,Yuan Wang,Hang-zi Chen,Yong-zhen Xing,Feng-wei Li,Qian Zhang,Bo Zhou,Hong-Kui Zhang,Jie Zhang,Xue-li Bian,Li Li,Yuan Liu,Bi-xing Zhao,Yan Chen,Rong Wu,An-zhong Li,Lu-ming Yao,Chen Ping,Yi Zhang,Xu-yang Tian,Friedrich Beermann,Mian Wu,Jiahuai Han,Pei-Qiang Huang,Tianwei Lin,Qiao Wu +25 more
TL;DR: It is discovered that melanoma, which is generally resistant to drug-induced apoptosis, can undergo autophagic cell death with the participation of orphan nuclear receptor TR3, and implicates a new approach to melanoma therapy through activation of a mitochondrial signaling pathway that integrates a nuclear receptor with autophagy for cell death.
Journal ArticleDOI
Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment
Pei-pei Hou,Li-juan Luo,Hang-zi Chen,Qi-tao Chen,Xue-li Bian,Sheng-fu Wu,Jia-xin Zhou,Wenxiu Zhao,Jianming Liu,Xiaomin Wang,Zhi-yuan Zhang,Lu-ming Yao,Qinghua Chen,Dawang Zhou,Qiao Wu +14 more
TL;DR: It is demonstrated that hepatocellular carcinoma (HCC)-derived ectosomes remodel the tumor microenvironment to facilitate HCC progression in an ectosomal PKM2-dependent manner and is revealed as a potential diagnostic marker for HCC.
Journal ArticleDOI
The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling
Hang-zi Chen,Qing-Feng Liu,Li Li,Wei-jia Wang,Lu-ming Yao,Meng Yang,Bo Liu,Wei Chen,Yan-yan Zhan,Ming-Qing Zhang,Cai Jianchun,Zhonghui Zheng,Sheng-Cai Lin,Bo-An Li,Qiao Wu +14 more
TL;DR: TR3 is a negative regulator of Wnt signalling and thus significantly suppresses intestinal tumorigenesis in Apcmin/+ mice, and this inhibitory effect of TR3 may be paradoxically overcome through phosphorylation by GSK3β in clinical colorectal cancers.
Journal ArticleDOI
Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis
TL;DR: It is demonstrated that cisplatin effectively induces orphan nuclear receptor TR3 phosphorylation by activating Chk2 kinase activity and promoting cross talk between these two proteins, thereby contributing to the repression of intestinal tumorigenesis via apoptosis.
Journal ArticleDOI
Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression.
Jian-ping He,Pei-pei Hou,Qi-tao Chen,Wei-jia Wang,Xiao-yu Sun,Peng-bo Yang,Ying-ping Li,Lu-ming Yao,Xiaotong Li,Xin-Dong Jiang,Kun-Yi Chien,Zhi-Ming Zhang,Qiu-Wan Wu,Allison J. Cowin,Qiao Wu,Hang-zi Chen +15 more
TL;DR: It is reported that Flightless-I, a novel p62-interacting protein, promotes breast cancer progression by impeding selective autophagy by interacting with p62 to block its recognition of LC3, leading to tumorigenesis in breast cancer.